BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes skin and soft-tissue infection (SSTI) in military recruits. OBJECTIVE: To evaluate the effectiveness of 2% chlorhexidine gluconate (CHG)-impregnated cloths in reducing rates of SSTI and S. aureus colonization among military recruits. DESIGN: A cluster-randomized (by platoon), double-blind, controlled effectiveness trial. SETTING: Marine Officer Candidate School, Quantico, Virginia, 2007. PARTICIPANTS: Military recruits. INTERVENTION: Application of CHG-impregnated or control (Comfort Bath; Sage) cloths applied over entire body thrice weekly. MEASUREMENTS: Recruits were monitored daily for SSTI. Baseline and serial nasal and/or axillary swabs were collected to assess S. aureus colonization. RESULTS: Of 1,562 subjects enrolled, 781 (from 23 platoons) underwent CHG-impregnated cloth application and 781 (from 21 platoons) underwent control cloth application. The rate of compliance (defined as application of 50% or more of wipes) at 2 weeks was similar (CHG group, 63%; control group, 67%) and decreased over the 6-week period. The mean 6-week SSTI rate in the CHG-impregnated cloth group was 0.094, compared with 0.071 in the control group (analysis of variance model rate difference, 0.025 ± 0.016; P = .14). At baseline, 43% of subjects were colonized with methicillin-susceptible S. aureus (MSSA), and 2.1% were colonized with MRSA. The mean incidence of colonization with MSSA was 50% and 61% (P = .026) and with MRSA was 2.6% and 6.0% (P = .034) for the CHG-impregnated and control cloth groups, respectively. CONCLUSIONS: CHG-impregnated cloths applied thrice weekly did not reduce rates of SSTI among recruits. S. aureus colonization rates increased in both groups but to a lesser extent in those assigned to the CHG-impregnated cloth intervention. Antecedent S. aureus colonization was not a risk factor for SSTI. Additional studies are needed to identify effective measures for preventing SSTI among military recruits. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier: NCT00475930.
RCT Entities:
BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes skin and soft-tissue infection (SSTI) in military recruits. OBJECTIVE: To evaluate the effectiveness of 2% chlorhexidine gluconate (CHG)-impregnated cloths in reducing rates of SSTI and S. aureus colonization among military recruits. DESIGN: A cluster-randomized (by platoon), double-blind, controlled effectiveness trial. SETTING: Marine Officer Candidate School, Quantico, Virginia, 2007. PARTICIPANTS: Military recruits. INTERVENTION: Application of CHG-impregnated or control (Comfort Bath; Sage) cloths applied over entire body thrice weekly. MEASUREMENTS: Recruits were monitored daily for SSTI. Baseline and serial nasal and/or axillary swabs were collected to assess S. aureus colonization. RESULTS: Of 1,562 subjects enrolled, 781 (from 23 platoons) underwent CHG-impregnated cloth application and 781 (from 21 platoons) underwent control cloth application. The rate of compliance (defined as application of 50% or more of wipes) at 2 weeks was similar (CHG group, 63%; control group, 67%) and decreased over the 6-week period. The mean 6-week SSTI rate in the CHG-impregnated cloth group was 0.094, compared with 0.071 in the control group (analysis of variance model rate difference, 0.025 ± 0.016; P = .14). At baseline, 43% of subjects were colonized with methicillin-susceptible S. aureus (MSSA), and 2.1% were colonized with MRSA. The mean incidence of colonization with MSSA was 50% and 61% (P = .026) and with MRSA was 2.6% and 6.0% (P = .034) for the CHG-impregnated and control cloth groups, respectively. CONCLUSIONS:CHG-impregnated cloths applied thrice weekly did not reduce rates of SSTI among recruits. S. aureus colonization rates increased in both groups but to a lesser extent in those assigned to the CHG-impregnated cloth intervention. Antecedent S. aureus colonization was not a risk factor for SSTI. Additional studies are needed to identify effective measures for preventing SSTI among military recruits. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier: NCT00475930.
Authors: Michael W Ellis; Carey D Schlett; Eugene V Millar; Kenneth J Wilkins; Katrina B Crawford; Stephanie M Morrison-Rodriguez; Laura A Pacha; Rachel J Gorwitz; Jeffrey B Lanier; David R Tribble Journal: Clin Infect Dis Date: 2014-03-14 Impact factor: 9.079
Authors: Carey D Schlett; Eugene V Millar; Katrina B Crawford; Tianyuan Cui; Jeffrey B Lanier; David R Tribble; Michael W Ellis Journal: Antimicrob Agents Chemother Date: 2014-05-19 Impact factor: 5.191
Authors: Eugene V Millar; Carey D Schlett; Natasha N Law; Timothy J Whitman; Michael W Ellis; David R Tribble; Jason W Bennett Journal: Mil Med Date: 2019-11-01 Impact factor: 1.437
Authors: Stephanie A Fritz; Patrick G Hogan; Bernard C Camins; Ali J Ainsworth; Carol Patrick; Madeline S Martin; Melissa J Krauss; Marcela Rodriguez; Carey-Ann D Burnham Journal: Antimicrob Agents Chemother Date: 2012-11-12 Impact factor: 5.191
Authors: Stephanie M Morrison; Carl R Blaesing; Eugene V Millar; Uzo Chukwuma; Carey D Schlett; Kenneth J Wilkins; David R Tribble; Michael W Ellis Journal: Infect Control Hosp Epidemiol Date: 2013-06-27 Impact factor: 3.254
Authors: Michael L Landrum; Tahaniyat Lalani; Minoo Niknian; Jason D Maguire; Duane R Hospenthal; Ali Fattom; Kimberly Taylor; Jamie Fraser; Kenneth Wilkins; Michael W Ellis; Paul D Kessler; Rafaat E F Fahim; David R Tribble Journal: Hum Vaccin Immunother Date: 2016-12-23 Impact factor: 3.452
Authors: Stephanie A Fritz; Patrick G Hogan; Genevieve Hayek; Kimberly A Eisenstein; Marcela Rodriguez; Emma K Epplin; Jane Garbutt; Victoria J Fraser Journal: Clin Infect Dis Date: 2011-12-23 Impact factor: 9.079
Authors: Eugene V Millar; Wei-Ju Chen; Carey D Schlett; Tianyuan Cui; Katrina B Crawford; Jeffrey B Lanier; David R Tribble; Michael W Ellis Journal: Antimicrob Agents Chemother Date: 2014-11-24 Impact factor: 5.191